EWY vs XBI
iShares MSCI South Korea ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.59% for EWY.
- • EWY pays a higher dividend yield (1.01%).
Side-by-side metrics
| Metric | EWY | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.59% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.01% | 0.36% |
AUM Assets under management — bigger funds are typically more liquid. | $24.47B | $10.73B |
YTD return | 87.94% | 33.79% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.40 | 1.10 |
P/E ratio | 18.30 | — |
Last price | $185.09 | $164.01 |
Inception | — | — |
Issuer | iShares | State Street |
EWY top holdings
| 000660.KS | SK Hynix Inc | 27.17% |
| 005930.KS | Samsung Electronics Co Ltd | 23.19% |
| 402340.KS | SK Square | 4.26% |
| 009150.KS | Samsung Electro-Mechanics Co Ltd | 3.63% |
| 005380.KS | Hyundai Motor Co | 1.74% |
| 105560.KS | KB Financial Group Inc | 1.58% |
| 028260.KS | Samsung C&T Corp | 1.19% |
| 055550.KS | Shinhan Financial Group Co Ltd | 1.19% |
| 034020.KS | Doosan Enerbility Co Ltd | 1.11% |
| 032830.KS | Samsung Life Insurance Co Ltd | 1.06% |
XBI top holdings
| APGE | Apogee Therapeutics Inc | 1.49% |
| MRNA | Moderna Inc | 1.41% |
| TWST | Twist Bioscience Corp | 1.41% |
| ORKA | Oruka Therapeutics Inc | 1.38% |
| KYMR | Kymera Therapeutics Inc Ordinary Shares | 1.36% |
| VKTX | Viking Therapeutics Inc | 1.30% |
| PRAX | Praxis Precision Medicines Inc Ordinary Shares | 1.29% |
| ERAS | Erasca Inc | 1.27% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.20% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.20% |
About EWY
EWY (iShares MSCI South Korea ETF) is South Korean large and mid-cap equities. Managed by iShares, the fund carries $24.5B in assets under management, an expense ratio of 0.59%, a dividend yield of 1.01%. Its largest holding is SK Hynix Inc (000660.KS), which represents 27.2% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 4.7%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.7B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.36%. Its largest holding is Apogee Therapeutics Inc (APGE), which represents 1.5% of the portfolio. Financial Services is the fund's largest sector exposure at 0.5%.